Surface tension effects on compliance

Surface Tension & Compliance - The Bubble Trouble

• The thin fluid layer lining alveoli creates surface tension, an inward-pulling force that opposes lung inflation (↓ compliance) and promotes collapse (atelectasis).
• Law of Laplace: Describes this collapsing pressure as $P = 2T/r$ (Pressure = 2 × Tension / radius).
  • This implies smaller alveoli (↓ radius) are more prone to collapse than larger ones.
• Pulmonary Surfactant: Secreted by Type II pneumocytes, primarily dipalmitoylphosphatidylcholine (DPPC).
  • It disrupts the cohesive forces between water molecules, reducing surface tension.
  • This action increases compliance and stabilizes alveoli, preventing atelectasis.

⭐ In Neonatal Respiratory Distress Syndrome (NRDS), a deficiency of surfactant leads to high surface tension, causing widespread alveolar collapse and severe breathing difficulty.

Pulmonary Surfactant - Soapy Super-Stabilizer

• Composition & Source: A lipoprotein complex, rich in dipalmitoylphosphatidylcholine (DPPC). Synthesized and secreted by Type II pneumocytes.

• Primary Function: Reduces surface tension at the air-liquid interface within alveoli.

  • Disrupts the hydrogen bonds between water molecules.
  • Results in ↑ pulmonary compliance and ↓ work of breathing.
  • Prevents alveolar collapse (atelectasis), especially during expiration.

• Law of Laplace & Stability: $P = 2T/r$

  • P=Collapsing pressure, T=Surface tension, r=Radius.
  • Without surfactant, smaller alveoli (↓r) would have ↑P and empty into larger ones.
  • Surfactant's effect is radius-dependent; it reduces T more in smaller alveoli, equalizing pressures and stabilizing them.

⭐ In Neonatal Respiratory Distress Syndrome (NRDS), surfactant deficiency in premature infants causes high alveolar surface tension, leading to diffuse atelectasis and respiratory failure. Antenatal corticosteroids are a key intervention.

Clinical Correlates - When the Bubble Bursts

• Neonatal Respiratory Distress Syndrome (NRDS)

  • Cause: Prematurity (< 35 weeks gestation) → insufficient surfactant production by Type II pneumocytes.
  • Pathophysiology: ↑ surface tension → widespread alveolar collapse (atelectasis) → ↓ lung compliance, ↓ Functional Residual Capacity (FRC), and severe V/Q mismatch.
  • Tx: Antenatal corticosteroids to mother; exogenous surfactant to infant.

• Acute Respiratory Distress Syndrome (ARDS)

  • Cause: Lung injury (sepsis, pneumonia, trauma) damages pneumocytes and inactivates surfactant.
  • Pathophysiology: Protein-rich edema fluid enters alveoli, disrupting the surfactant layer → ↑ surface tension, non-cardiogenic pulmonary edema, and stiff, poorly compliant lungs.

⭐ The lecithin-to-sphingomyelin (L/S) ratio in amniotic fluid assesses fetal lung maturity. A ratio > 2.0 indicates low risk of NRDS.

High‑Yield Points - ⚡ Biggest Takeaways

• Pulmonary surfactant, secreted by Type II pneumocytes, profoundly reduces alveolar surface tension.
• This reduction increases lung compliance, making it easier to inflate the lungs, and prevents atelectasis (collapse).
• Its primary component is dipalmitoylphosphatidylcholine (DPPC).
• Per the Law of Laplace, surfactant's effect is greatest in smaller alveoli, preventing them from collapsing into larger ones.
• A deficiency causes Neonatal Respiratory Distress Syndrome (NRDS).